Pellegrini–Stieda syndrome

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Pellegrini–Stieda syndrome
Synonyms
Pronounce
Specialty Orthopedics
Symptoms Knee pain, swelling
Complications
Onset
Duration
Types
Causes Trauma to the knee
Risks
Diagnosis X-ray, MRI
Differential diagnosis
Prevention
Treatment Physical therapy, NSAIDs, surgery
Medication
Prognosis
Frequency
Deaths


Pellegrini–Stieda syndrome
Error creating thumbnail: File missing
Pellegrini–Stieda syndrome
Pellegrini–Stieda syndrome
Pellegrini–Stieda syndrome
Pellegrini–Stieda syndrome

Pellegrini–Stieda syndrome is a medical condition characterized by pain and stiffness in the knee. It is caused by calcification at the site of a previous injury to the medial collateral ligament of the knee. The syndrome is named after Italian surgeon Augusto Pellegrini and German radiologist Alban Köhler.

Symptoms[edit]

The primary symptom of Pellegrini–Stieda syndrome is pain in the knee, particularly on the inner side. This pain is often accompanied by stiffness and a reduced range of motion. The pain may be exacerbated by physical activity, particularly activities that involve bending or twisting the knee.

Causes[edit]

Pellegrini–Stieda syndrome is caused by calcification at the site of a previous injury to the medial collateral ligament of the knee. This calcification is thought to result from a process called heterotopic ossification, in which bone tissue forms in places where it should not. The exact cause of this process is not fully understood, but it is thought to be related to inflammation and tissue damage.

Diagnosis[edit]

The diagnosis of Pellegrini–Stieda syndrome is typically made based on the patient's symptoms and the results of imaging studies. X-rays of the knee can often reveal the characteristic calcification at the site of the medial collateral ligament. In some cases, other imaging studies such as MRI or CT scans may be used to confirm the diagnosis and rule out other conditions.

Treatment[edit]

The treatment of Pellegrini–Stieda syndrome typically involves a combination of conservative measures and, in some cases, surgery. Conservative measures may include rest, physical therapy, and the use of nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. If these measures are not effective, surgery may be considered to remove the calcified tissue.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.